VTRL.Y Stock Overview
Provides assisted reproduction products. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Vitrolife AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 19.10 |
52 Week High | SEK 25.00 |
52 Week Low | SEK 16.25 |
Beta | 1.8 |
11 Month Change | -23.60% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | 16.82% |
Change since IPO | 61.86% |
Recent News & Updates
Recent updates
Shareholder Returns
VTRL.Y | US Biotechs | US Market | |
---|---|---|---|
7D | 0% | 4.0% | 2.0% |
1Y | n/a | 18.0% | 32.4% |
Return vs Industry: Insufficient data to determine how VTRL.Y performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how VTRL.Y performed against the US Market.
Price Volatility
VTRL.Y volatility | |
---|---|
VTRL.Y Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 9.8% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VTRL.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine VTRL.Y's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 1,111 | Bronwyn Brophy O´Connor | www.vitrolife.com |
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems.
Vitrolife AB (publ) Fundamentals Summary
VTRL.Y fundamental statistics | |
---|---|
Market cap | US$2.75b |
Earnings (TTM) | -US$346.00m |
Revenue (TTM) | US$323.27m |
8.5x
P/S Ratio-7.9x
P/E RatioIs VTRL.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VTRL.Y income statement (TTM) | |
---|---|
Revenue | SEK 3.56b |
Cost of Revenue | SEK 1.49b |
Gross Profit | SEK 2.07b |
Other Expenses | SEK 5.87b |
Earnings | -SEK 3.80b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
Earnings per share (EPS) | -28.10 |
Gross Margin | 58.17% |
Net Profit Margin | -107.03% |
Debt/Equity Ratio | 14.6% |
How did VTRL.Y perform over the long term?
See historical performance and comparison